ANIP News and Press, ANI Pharmaceuticals Inc. From 10/02/19

BAUDETTE, Minn. , Oct. 2, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg (the generic equivalent of Aggrenox®).  This launch represents ANI's fifth generic product...

ANI Pharmaceuticals (NASDAQ: ANIP ) initiated with Buy rating and $76 (9% upside) price target at Guggenheim. More news on: ANI Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

BAUDETTE, Minn. , Sept. 11, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Vancomycin HCl for Oral Solution, 250mg per 5mL (the generic equivalent to ANI's Vancocin® for Oral Solution).  To facilitate ease of adminis...

U.S. Senator Bernie Sanders (I-VT) and Representative Elijah Cummings (D-MD - 7th district) have launched an investigation targeting Teva Pharmaceutical Industries ( TEVA -8% ), Mylan N.V. ( MYL -7.8% ) and Heritage Pharmaceuticals for allegedly obstructing a Congressional inquiry into...

ANI Pharmaceuticals, Inc. (ANIP) Q2 2019 Earnings Conference Call August 07, 2019, 10:30 ET Company Participants Arthur Przybyl - President, CEO & Director Stephen Carey - CFO & VP of Finance Conference Call Participants Elliot Wilbur - Raymond James & Associates ...

ANI Pharmaceuticals ( ANIP -13.8% ) Q2 results : Revenues: $54.4M (+15.0%); Generic pharmaceutical products: $36.3M (+20.2%); Branded pharmaceutical products: $14M (+33.3%); Contract manufacturing: $3.7M (+117.6%); Royalty and other: $0.4M (-91.8%). More news on: ANI Pharmaceuticals, In...

ANI Pharmaceuticals (NASDAQ: ANIP ): Q2 Non-GAAP EPS of $1.44 beats by $0.16 ; GAAP EPS of $0.53 beats by $0.01 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

BAUDETTE, Minn. , Aug. 7, 2019 /PRNewswire/ -- For the second quarter 2019: Net revenues of $54.4 million , an increase of 15% versus prior year GAAP net income of $6.6 million and diluted GAAP earnings per share of $0.53 , increases of 137% and 130% versus prior year, res...

AMAG , ANIP , ATHM , ATKR , AVA , BCOR , BV , CNP , CORE , CPRI , CSTE , CVS , CYBR , DNR , DOC , ETM , EVOP , FUN , GOLF , GTN , HL , HZNP , ICPT , INGN , INXN , IONS , JELD , KELYA , LAMR , LL , LXP , MFA , MIDD , NRG , NVMI , NXST , NYT , ODP , OMI ...

BAUDETTE, Minn. , July 31, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its second quarter and year-to-date 2019 financial results on Wednesday, August 7, 2019 , before the opening of the U.S. financial markets. The earni...